Navigation Links
Light Sciences Oncology Announces Results of Study on Immunotherapeutic Mechanism of Aptocine(TM), a Novel Light-Activated Drug Therapy for Cancer
Date:5/18/2009

Preclinical Study is Subject of Upcoming ASCO Presentation

BELLEVUE, Wash., May 18 /PRNewswire/ -- Light Sciences Oncology, Inc. (LSO) today announced that a new preclinical study has yielded evidence that the company's novel light-activated drug Aptocine(TM) (formerly Litx(TM)) may enhance anti-tumor immunity and prevent metastases. Results of the study will be presented in a poster session at the annual American Society of Clinical Oncology (ASCO) meeting in Orlando, Florida, on May 30, 8:00 AM - 12:00 PM. The study was conducted by Dr. Sandra Gollnick at the Roswell Park Cancer Institute in Buffalo, New York.

"With mounting evidence that Aptocine may be an active immunotherapy in addition to its demonstrated ability to ablate tumors, this drug may offer greater benefit to cancer patients than initially contemplated. Dr. Gollnick's thorough and exhaustive study defines an immune effect in cancer which is unprecedented," said LSO's President and CEO Llew Keltner, M.D., Ph.D.

In the preclinical study, Aptocine was used to treat primary tumors and examine prevention of metastases in the 4T1 tumor model, an aggressive, spontaneously metastasizing murine mammary tumor model that mirrors human breast cancer. When grown in the mammary fat pad of BALB/c mice, untreated 4T1 tumors rapidly metastasize to the lung, liver, lymph nodes, and brain. Primary 4T1 tumors grown in mice were treated and animal survival was followed. To determine whether the therapy could enhance anti-tumor immunity and reduce metastases, the lymph node (LN) cells from treated and control mice were transferred to naive recipient mice. Recipients were challenged with a tumorigenic dose of 4T1 cells 3 days after adoptive transfer and primary and secondary tumor growth in the recipients was examined.

Key outcomes of the study include:

  • Aptocine treatment significantly prolonged survival in treated ani
    '/>"/>

SOURCE Light Sciences Oncology, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Stanford study highlights cost-effective method of lowering heart disease risks
2. Study shines more light on benefit of vitamin D in fighting cancer
3. Bacteria See the Light
4. Quantum light beams good for fast technology
5. Free will takes flight: how our brains respond to an approaching menace
6. New MRI finding sheds light on multiple sclerosis disease progressio
7. RA Drugs Linked to Slight Skin Cancer Risk
8. QUANTEL Intends to Strengthen its Dermatology/ Aesthetics Division With the Acquisition of WaveLight Aesthetic GmbH
9. REACH Registry Highlights That Patients With Peripheral Arterial Disease (PAD) Suffer High Rates of Heart Attack, Stroke, Hospitalization, and Death
10. Cardiovascular Technologies to be Highlighted at 5th Annual Cleveland Clinic Medical Innovation Summit, Oct. 1-3
11. First Circuit Court of Appeals Rules Against Philip Morris in Lights Class Action
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2015)... Data Integrity Problems on the Rise: , ... Partners/Suppliers, **FDAnews Webinar**, May 19, 2015 — 1:30 p.m. ... integrity issues have become a common and ever increasing ... issues within manufacturing operations or partner networks can be ... remediating them can be even more difficult. , ...
(Date:4/27/2015)... Cannabix Technologies Inc. (CSE: BLO) (OTC ... Iannapollo has become an Advisor to Cannabix Technologies, developer ... and workplace testing. Mr. Iannapollo is an expert on ... experience in the oil and gas industry, working for ... employer, and DOT compliance policies and strategies. He also ...
(Date:4/27/2015)... The global coagulation analyzers market ... in developed countries; however, it is expected to ... China, India and Brazil in the next five ... driven by factors such as increasing adoption of ... high-throughput hemostasis analyzers, developments in high-sensitivity point-of-care coagulation ...
(Date:4/27/2015)... 2015 The Global Pharmaceutical Packaging Market ... CAGR of 5.9% during the period 2015 – 2019. ... materials healthcare packaging market, mainly due to their cost ... market is extremely fragmented with the presence of ... of the market with the rest being occupied by ...
(Date:4/27/2015)... (PRWEB) April 27, 2015 On the ... the dramatic nighttime skyline of beautiful Los Angeles, CA, ... host, star of “The Real Housewives of Orange County” ... Durkin Entertainment’s EcoLuxe Lounge and the “Salute to the ... center for substance abuse founded by Wickstrom, Rossi felt ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 2Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 3Health News:FDAnews Announces — Data Integrity Problems on the Rise: Confronting Data Integrity Issues Within Your Operations or Your Partners/Suppliers Webinar, May 19, 2015 4Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 2Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 3Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 4Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 2Health News:Coagulation Analyzers Market Concluded to Reach $3.58 billion by 2019 3Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 2Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 3Health News:Global Pharmaceutical Packaging Market to Grow at 5% CAGR to 2019 Says a New Report at RnRMarketResearch.com 4Health News:Per Wickstrom Shares His Vision of Choices Recovery with Reality TV Star Gretchen Christine Rossi 2
... are worried about whether sporadic outbreaks of bird flu could ... impact of the H5N1 bird flu infection has been minimal ... a million lives, worldwide. ,The bird flu virus ... it has not inherited genetic changes that would enable human ...
... the cards that will be a landmark on the EM ... project which will come up// in two phases that will ... cancer patients. Bangalore and Ahmedabad will follow suit with ... Foundation chairman, had a meeting with the chief minister to ...
... of the leading insomnia drug companies. But at present it is ... this October. There's a range of insomnia drugs on the market, ... for some of the people who depend on Ambien for a ... supply for the French pharmaceutical company of late. A string of ...
... division, Loyola University Health System, Maywood, Ill has noted that ... NCAA Tournament // on the television screens turns even the ... is important to prevent injuring oneself even as you enjoy ... especially painful and require months of rehabilitation, so it’s best ...
... claimed two more lives, as informed by regulators who issued ... combination from the market. The drug combination, also called Mifeprex ... in any of those cases//. ,The Food and Drug ... infection previously implicated in four deaths of women who had ...
... Health Service in Wales will end this financial year ?71m ... that confirmed by the National Health Service in Wales will ... also been confirmed by the assembly government. It is a ... budget for the Welsh NHS is around ?4.9bn. ...
Cached Medicine News:Health News:Ambien and the Other Insomnia Drugs 2
(Date:4/27/2015)... , April 27, 2015 ... completed filing of a Pre-Marketing Notification Application (510k) with ... BRH-A2 Wound Management System. BRH Medical expects feedback from ... the US market with BRH-A2 following FDA pre-market clearance. ... Motti Oderberg , CEO for BRH Medical, ...
(Date:4/27/2015)... , April 27, 2015 TWi Pharmaceuticals, ... into a Settlement Agreement with Takeda Pharmaceutical Company ... Inc., Takeda Pharmaceuticals America, Inc. (individually and collectively, ... litigation related to TWi,s generic dexlansoprazole delayed release ... 60 mg dosage strengths. An Abbreviated New Drug Application ...
(Date:4/24/2015)... NASHUA, New Hampshire , und ... 2015 (Stand Nr. 4410) iCAD, ... führender Anbieter von moderner Bildanalyse, Lösungen für ... Behandlung von Krebserkrankungen, hat heute die sofortige ... ® Electronic Brachytherapy (eBx ® ) ...
Breaking Medicine Technology:BRH Medical, Ltd., Announces Filing of a Pre-Market Submission with the US Food and Drug Administration (FDA) for the BRH-A2 Tissue Management System 2TWi Announces Settlement with Takeda on Dexilant(R) Litigation 2Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 2Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 3Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 4Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 5Erste Klinik in Spanien setzt das Xoft Electronic Brachytherapy System für die Behandlung von Brustkrebs im Frühstadium, nicht-melanozytärem Hautkrebs und gynäkologischen Krebserkrankungen ein 6
... YORK, Jan. 20, 2011 Reportlinker.com announces that ... its catalogue: Hospital Radiography & ... This is the most comprehensive ... radiology modality types (General Radiology, Mammography, R&F, Angiography, ...
... 2011 CyberKnife Center of Miami ( www.cyberknifemiami.com ... FACRO, FASTRO, announces a presentation regarding CyberKnife Treatment ... Association of Neurosurgeon,s Annual Meeting, on January 28, ... http://photos.prnewswire.com/prnh/20110120/FL32893 ) The presentation is ...
Cached Medicine Technology:Reportlinker Adds Hospital Radiography & Fluoroscopy Census 2CyberKnife Center of Miami to Present at 38th Annual Caribbean Association of Neurosurgeon's Conference 2
This new dedicated VICTOR2 model is for fluorescence and luminescence measurements....
... VICTOR2 V measures ... polarization, luminescence, time-resolved ... absorbance. A red-sensitive ... assay. All technologies ...
... is the modular VICTOR2 ... high density TR-fluorometry, stacker ... The extra high density ... excitation beam for TRF ...
Flexible and sensitive fluorescence/luminescence microplate reader for endpoint and kinetic...
Medicine Products: